Ocrelizumab is granted EU licence for primary progressive and relapsing remitting MS
The European Commission (EC) has granted a licence for the use of ocrelizumab, also known as Ocrevus, in people with primary progressive multiple sclerosis (PPMS) and relapsing remitting multiple sclerosis (RRMS)…Read more - http://www.ms-uk.org/ocrelizumab-grante ... mitting-ms
Ocrelizumab is granted EU licence for PPMS and RRMS
Ocrelizumab is granted EU licence for PPMS and RRMS
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11117 Views
-
Last post by NHE
-
- 0 Replies
- 1035 Views
-
Last post by NHE
-
- 0 Replies
- 1607 Views
-
Last post by NHE
-
- 0 Replies
- 680 Views
-
Last post by DIM
-
- 0 Replies
- 2354 Views
-
Last post by NHE
-
- 1 Replies
- 1311 Views
-
Last post by vesta
-
- 0 Replies
- 1964 Views
-
Last post by frodo
-
- 0 Replies
- 1881 Views
-
Last post by NHE
-
- 0 Replies
- 1445 Views
-
Last post by NHE